Trial Profile
Phase 1 study of KBP-042 in patients with with type 2 diabetes, obesity and non-alcoholic steatohepatitis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Sep 2016
Price :
$35
*
At a glance
- Drugs KBP 042 (Primary)
- Indications Non-alcoholic steatohepatitis; Obesity; Type 2 diabetes mellitus
- Focus Adverse reactions
- 12 Sep 2016 New trial record